Navigation Links
NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
Date:11/3/2010

w.nxstage.com/.

Forward-Looking Statements This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2010. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Kristen K. Sheppard, Esq. Investor Relations ksheppard@nxstage.com
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Flexpoint Ford, a private ... sectors, today announced that it has entered into a ... Stuart to form Kastle Therapeutics, LLC (Kastle).  The ... will focus on acquiring, developing and commercializing pharmaceuticals targeted ... opportunities include select therapies already approved for marketing, as ...
(Date:7/30/2015)... FRAMINGHAM, Mass., July 30, 2015   HeartWare ... leading innovator of less invasive, miniaturized circulatory support ... heart failure, today announced total revenue of $73.6 ... compared to $70.1 million for the quarter ended ... by approximately $6.0 million, or nine percentage points, ...
(Date:7/30/2015)... 30, 2015  IDEXX Laboratories, Inc. (NASDAQ: IDXX ... 2015 of $413 million, an increase of 6% compared ... of the US dollar reduced reported revenue growth by ... quarter was 11%, supported by strong growth in the ... share ("EPS") was $0.60 for the quarter, an increase ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile ... lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. Dr. ... made him popular with many patients from around the world. , “Like treatment of ...
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of its ... to apply lotion or medication to a hard-to-reach area. This invention is patented. , ... to the back, and provides thorough coverage. The product would prevent the user from ...
(Date:7/30/2015)... , ... July 30, 2015 , ... After conducting a ... St. John’s Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) ... With more than 25 years of healthcare leadership experience, Walsh is an expert in ...
(Date:7/30/2015)... ... July 30, 2015 , ... According ... do not find a complete removable denture acceptable. The demand for dental implants ... that incorporate less expensive, immediate loading techniques will have the ability to offer ...
(Date:7/30/2015)... ... July 30, 2015 , ... Diagnotes, ... and reporting for reimbursement from the Centers for Medicare & Medicaid Services (CMS) ... providers are experimenting with manual data capture or, in many cases, just deciding ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 2Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 3
... ... Removal System , ... (Vocus) January 8, 2010 -- After more than 20 years with very little innovation, the ... a new tool for cast removal. , , , , ,With an operating sound level ...
... ... Make Moves to Advance Expansion as EHS Industry Explodes. , ... Vancouver, Washington (PRWEB) January 8, 2010 -- ... as Vice President of Partners and Strategy. In this role, Jim will focus ...
... , , , , WEST ... , a leading provider of digital office equipment, today ... professionals seeking to streamline paper-intensive medical processes. Held in seven ... both the healthcare and information technology industries on critical steps ...
... Calif., Jan. 8 TRIA Beauty, the leader in ... (OTC) clearance from the United States Food and Drug ... for at-home use. The patented blue light technology ... inflammatory acne. , "This new platform validates TRIA Beauty,s ...
... , FRANKLIN LAKES, N.J., Jan. 8 ... BDX ), a leading global medical technology ... President,s Emergency Plan for AIDS Relief (PEPFAR) will increase ... health systems in developing countries. , BD currently collaborates ...
... with asthma, heart and lung disease, among others, agency ... U.S. Environmental Protection Agency on Thursday proposed stricter standards ... of health problems, including aggravated asthma and premature death ... standards, if adopted by the agency after a 60-day ...
Cached Medicine News:Health News:New 'Kid-Friendly' Cast Removal Tool Now at Sanford 2Health News:Seasoned Executive Joins Safetec To Accelerate Growth 2Health News:Ricoh Offers Free Educational Sessions to Healthcare Professionals Nationwide 2Health News:Ricoh Offers Free Educational Sessions to Healthcare Professionals Nationwide 3Health News:Ricoh Offers Free Educational Sessions to Healthcare Professionals Nationwide 4Health News:TRIA Beauty Announces FDA Clearance 2Health News:BD Applauds PEPFAR's Broadened Emphasis on Strengthening Health Systems 2Health News:BD Applauds PEPFAR's Broadened Emphasis on Strengthening Health Systems 3Health News:EPA Unveils Stricter Smog Standards 2Health News:EPA Unveils Stricter Smog Standards 3
Complete product line for typing all classical HLA loci including A, B, C DRA, DRB1, DRB3, DRB4, DRB5, DQA, DQB1, DPA1, and DPB1....
... Our Class II Direct to High Res SSP ... with a single tray. Locus specific typing on a ... time. , Straight from genomic DNA to high ... , Allele level typing with a single tray , ...
... Our Class I Direct to High Res SSP ... with a single tray. Locus specific typing on a ... time. , Straight from genomic DNA to high ... , Allele level typing with a single tray , ...
... High Res SSP kits provide high resolution typing of ... typing on a single tray reduces QC and testing ... DNA to high resolution results, no need for initial ... single tray , Unique reaction pattern for most common ...
Medicine Products: